TCW Group’s Immunomedics Inc IMMU Stock Holding History

TCW Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,978	Closed	-$1.7M	–	359
2020 Q3	$1.7M	Sell	19,978 -7,160	-26%	-$362K	0.02%	236
2020 Q2	$962K	Sell	27,138 -17,266	-39%	-$505K	0.01%	244
2020 Q1	$599K	Buy	44,404 +15,829	+55%	+$266K	0.01%	267
2019 Q4	$605K	Sell	28,575 -274	-0.9%	-$4.83K	0.01%	261
2019 Q3	$383K	Buy	+28,849	New	+$424K	﹤0.01%	280

TCW Group's IMMU Position: Q4 2020 in Review

TCW Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 19,978 shares — an estimated $1.7M sold.

TCW Group first reported a position in IMMU in Q3 2019 and held it in 5 quarters. The position peaked at $1.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

TCW Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
TCW Group sold 19,978 Immunomedics Inc shares in Q4 2020, an estimated $1.7M.
TCW Group first reported a position in Immunomedics Inc in Q3 2019 and held it in 5 quarters.
TCW Group's Immunomedics Inc position peaked at $1.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on TCW Group's 13F filing for Q4 2020, filed 2 Feb 2021.